Securities code: Fujian Cosunter Pharmaceutical Co.Ltd(300436) securities abbreviation: Fujian Cosunter Pharmaceutical Co.Ltd(300436) Announcement No.: 2022043 Fujian Cosunter Pharmaceutical Co.Ltd(300436)
Announcement on bank loan limit and guarantee in 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Fujian Cosunter Pharmaceutical Co.Ltd(300436) (hereinafter referred to as “the company”) and its subsidiaries (subsidiaries and their subsidiaries within the scope of consolidated statements, the same below) intend to apply to the bank for a comprehensive credit line and apply for loans to meet the needs of production, operation and development, and provide guarantee within the loan line. On April 21, 2022, the company held the 13th meeting of the Fourth Board of directors, deliberated and adopted the proposal on bank loan limit and guarantee in 2022. This proposal still needs to be submitted to the 2021 annual general meeting of shareholders for deliberation.
1、 Application for bank loan limit and guarantee
In order to meet the needs of production, operation and development, the company and its subsidiaries intend to apply to the bank for comprehensive credit. The types of credit include but are not limited to working capital loan, letter of credit, bank acceptance bill, letter of guarantee, trade financing of accounts receivable, ultra short financing bill credit, construction project loan, M & a loan and other businesses (the specific credit bank, credit line and credit term shall be subject to the actual approval), The total amount of loans applied for shall not exceed 350 million yuan or equivalent foreign currency. The specific amount of loans will be determined according to the actual capital needs of the company and its subsidiaries for daily operation and business development (finally, the actual amount of loans incurred by the company and its subsidiaries shall prevail).
The company and its subsidiaries provide guarantees within the above total loan amount of 350 million yuan, including guarantees provided by the company or its subsidiaries with their own assets, guarantees provided by the company for its subsidiaries, guarantees provided by subsidiaries for the company and mutual guarantees provided by subsidiaries. The specific guarantee methods include but are not limited to guarantee, mortgage, pledge and so on. The validity period of the above loan and guarantee line is one year from the date of deliberation and approval by the general meeting of shareholders of the company, and the loan and guarantee line can be recycled within the validity period.
In order to facilitate the implementation of bank loans and guarantees, the board of directors of the company plans to submit to the general meeting of shareholders to authorize the management to be responsible for the specific implementation of credit, loans and guarantees within the loan limit and guarantee limit. 2、 Basic information of the guaranteed
The bank loan guarantee in 2022 is the guarantee between the company and its subsidiaries, including the company or its subsidiaries
Self owned assets provide guarantee, the company provides guarantee for subsidiaries, subsidiaries provide guarantee for the company, and subsidiaries
Provide mutual guarantee between companies.
1. Basic information of subsidiaries
Name of subsidiary company date of incorporation legal representative registered capital business nature shareholding ratio
Table person (10000 yuan) direct and indirect
Fujian Fujian Cosunter Pharmaceutical Co.Ltd(300436) pharmaceutical sales October 10, 2015 Fujian huangfuhu pharmaceutical sales
Fuzhou Co., Ltd. 300000 100.00%
Fujian Guangsheng hospital Co., Ltd. August 8, 2017 Fujian Li Yuanli maternal and child health care medical service
Director Le City 1000000 100.00%
Fujian Fujian Cosunter Pharmaceutical Co.Ltd(300436) Jintang Pharmaceutical Co., Ltd. August 16, 2017 Fujian Li Hongming Pharmaceutical Co., Ltd
Shaowu 1400000 100.00%
Fujian Huayi Internet hospital August 31, 2017 Fujian Li Yuanli maternal and child health care medical service
Fuzhou Co., Ltd. 1000000 100.00%
Fujian Cosunter Pharmaceutical Co.Ltd(300436) assisted reproduction overseas September 29, 2017 China’s R & D and transfer of reproductive technology
Limited company Hong Kong – HK $10.00, consultation, service, etc. 100.00%
Fujian Fujian Cosunter Pharmaceutical Co.Ltd(300436) e-commerce April 19, 2016 Fujian huangfuhu pharmaceutical sales
Limited liability company Ningde 100000 100.00%
Fujian Fujian Cosunter Pharmaceutical Co.Ltd(300436) new drug R & D April 10, 2018 Fujian Li Hongming new drug R & D, production and marketing
Fuzhou 1000000 Sales Co., Ltd. 100.00%
Jiangsu Zhongxing pharmaceutical industry August 3, 2002 production and application of Zhang Zhijun’s traditional Chinese medicine preparations in Jiangsu Province
Zhenjiang 642857 Sales Co., Ltd. 94.17%
Fujian Guangsheng Zhonglin biology department November 22, 2021 Fujian Province Li Hongming medical research and Experimental Research Institute
Technology Co., Ltd. Ningde 3500000 exhibition 90.00%
2. Annual operation of subsidiaries in 2021 (unit: yuan)
Name of subsidiary total assets total liabilities net assets operating income net profit
Fujian Fujian Cosunter Pharmaceutical Co.Ltd(300436) Pharmaceutical Sales Co., Ltd. 5954608791458154594 Zhejiang Yueling Co.Ltd(002725) 530973 – 248281256
Fujian Guangsheng hospital Co., Ltd. 4449202121 – 4449202121 – 140418
Fujian Fujian Cosunter Pharmaceutical Co.Ltd(300436) Jintang Pharmaceutical Co., Ltd. 11173540432948763720989693731 -3377363731685903223
Fujian Huayi Internet hospital Co., Ltd. 3772166003 – 3772166003 — 31398095
Fujian Cosunter Pharmaceutical Co.Ltd(300436) assisted reproduction overseas Co., Ltd. —–
Fujian Fujian Cosunter Pharmaceutical Co.Ltd(300436) e-commerce Co., Ltd. 97982997 – 97982997 478.96 – 32132923
Fujian Fujian Cosunter Pharmaceutical Co.Ltd(300436) new drug research and Development Co., Ltd. 18962506 – 18962506 – 171545
Jiangsu Zhongxing Pharmaceutical Co., Ltd. 20232451074930839145710924059617187533875902080364449
Fujian Guangsheng Zhonglin Biotechnology Co., Ltd. 628153485148575159479578326 — 520421674
The financial data of Fujian Guangsheng hospital Co., Ltd. and Fujian Fujian Cosunter Pharmaceutical Co.Ltd(300436) Pharmaceutical Sales Co., Ltd. are the data of the parent company.
3. In addition to the existing subsidiaries, the guaranteed objects also include the bank loan limit and guarantee approved this time
New subsidiaries within the validity period of the quota.
3、 Main contents of the guarantee agreement
No agreement has been signed on this guarantee, which shall be subject to the guarantee agreement signed with relevant banks.
4、 Deliberation opinions
1. Opinions of the board of directors of the company
The board of Directors believes that the application for loan limit and guarantee from the bank will help to meet the capital needs of the company and its subsidiaries in the operation and development and improve the operation efficiency of the company. This guarantee is a guarantee between the company and its subsidiaries. The risk of providing guarantee is controllable and there is no damage to the interests of the company and all shareholders. 2. Opinions of independent directors
After verification, we believe that the application for loan limit and guarantee from the bank is for the needs of business development. The guarantee provided this time can improve the bank credit of all parties, help them solve the capital needs of production and operation, enhance their market competitiveness, comply with the company’s development strategy, and there is no situation that damages the interests of the company and all shareholders. This guarantee is between the company and its subsidiaries. The risk is controllable and will not adversely affect the normal operation and business development of the company and its subsidiaries. To sum up, we unanimously agree on the bank loan limit and guarantee.
3. Opinions of the board of supervisors
After review, the board of supervisors believes that the application for loan limit and guarantee from the bank this time will help to meet the capital needs of the company and its subsidiaries for operation and development, improve the operation efficiency of the company, and there is no damage to the interests of the company and shareholders. The bank loan limit and guarantee matters need to be submitted to the general meeting of shareholders for deliberation.
5、 Accumulated total amount of external guarantee and amount of overdue guarantee
As of the date of this announcement, except that the company or its subsidiaries provide guarantees with their own assets, there is no case that the company and its subsidiaries within the scope of the company’s consolidated statements provide guarantees to each other, and there is no case that the company and its subsidiaries within the scope of the company’s consolidated statements provide guarantees to third parties outside the scope of the consolidated statements.
6、 Documents for future reference
1. Resolutions of the 13th meeting of the 4th board of directors;
2. Resolutions of the 12th meeting of the 4th board of supervisors;
3. Independent opinions of independent directors on matters related to the 13th meeting of the Fourth Board of directors.
It is hereby announced.
Fujian Cosunter Pharmaceutical Co.Ltd(300436) board of directors April 21, 2022
